English
简体中文
Total: £ 56.28
Published Date: 2026-04-10 | Pages: 110 | Tables: 116 | Pharma & Healthcare
The global Long-acting Glucocorticoid Injection market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Long-acting Glucocorticoid Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Long-acting glucocorticoid injection is a drug with anti-inflammatory, anti-rheumatic and immunosuppressive effects, and is often used to treat allergic and autoimmune inflammatory diseases.
The North American market for Long-acting Glucocorticoid Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Long-acting Glucocorticoid Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Long-acting Glucocorticoid Injection include Eurocrit Labs, Pyxus Pharmaceutical, SiNi Pharma, Zydus Cadila, Weefsel Pharma, Taj Pharmaceuticals Limited, Wellona Pharma, Caspian Tamin Pharmaceutical Company, AdvaCare Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Long-acting Glucocorticoid Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Long-acting Glucocorticoid Injection. The Long-acting Glucocorticoid Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Long-acting Glucocorticoid Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Long-acting Glucocorticoid Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Eurocrit Labs
Pyxus Pharmaceutical
SiNi Pharma
Zydus Cadila
Weefsel Pharma
Taj Pharmaceuticals Limited
Wellona Pharma
Caspian Tamin Pharmaceutical Company
AdvaCare Pharma
Segment by Type
Dexamethasone Hormone Injection
Betamethasone Hormone Injection
by Application
Rheumatoid Arthritis
Allergic Diseases
Bronchial Asthma
Autoimmune Disease
Skin Diseases
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Long-acting Glucocorticoid Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Long-acting Glucocorticoid Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Long-acting Glucocorticoid Injection Market Overview
1.1 Product Definition
1.2 Long-acting Glucocorticoid Injection by Type
1.2.1 Global Long-acting Glucocorticoid Injection Market Value by Type: 2025 vs 2032
1.2.2 Dexamethasone Hormone Injection
1.2.3 Betamethasone Hormone Injection
1.3 Long-acting Glucocorticoid Injection by Application
1.3.1 Global Long-acting Glucocorticoid Injection Market Value by Application: 2025 vs 2032
1.3.2 Rheumatoid Arthritis
1.3.3 Allergic Diseases
1.3.4 Bronchial Asthma
1.3.5 Autoimmune Disease
1.3.6 Skin Diseases
1.3.7 Others
1.4 Global Long-acting Glucocorticoid Injection Market Size Estimates and Forecasts
1.4.1 Global Long-acting Glucocorticoid Injection Revenue 2021–2032
1.4.2 Global Long-acting Glucocorticoid Injection Sales 2021–2032
1.4.3 Global Long-acting Glucocorticoid Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Long-acting Glucocorticoid Injection Market Competition by Manufacturers
2.1 Global Long-acting Glucocorticoid Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Long-acting Glucocorticoid Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Long-acting Glucocorticoid Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Long-acting Glucocorticoid Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Long-acting Glucocorticoid Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Long-acting Glucocorticoid Injection, Product Types and Applications
2.7 Global Key Manufacturers of Long-acting Glucocorticoid Injection, Date of Entry into the Industry
2.8 Global Long-acting Glucocorticoid Injection Market Competitive Situation and Trends
2.8.1 Global Long-acting Glucocorticoid Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Long-acting Glucocorticoid Injection Players Market Share by Revenue
2.8.3 Global Long-acting Glucocorticoid Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Long-acting Glucocorticoid Injection Market Scenario by Region
3.1 Global Long-acting Glucocorticoid Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Long-acting Glucocorticoid Injection Sales by Region: 2021–2032
3.2.1 Global Long-acting Glucocorticoid Injection Sales by Region: 2021–2026
3.2.2 Global Long-acting Glucocorticoid Injection Sales by Region: 2027–2032
3.3 Global Long-acting Glucocorticoid Injection Revenue by Region: 2021–2032
3.3.1 Global Long-acting Glucocorticoid Injection Revenue by Region: 2021–2026
3.3.2 Global Long-acting Glucocorticoid Injection Revenue by Region: 2027–2032
3.4 North America Long-acting Glucocorticoid Injection Market Facts & Figures by Country
3.4.1 North America Long-acting Glucocorticoid Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Long-acting Glucocorticoid Injection Sales by Country (2021–2032)
3.4.3 North America Long-acting Glucocorticoid Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Long-acting Glucocorticoid Injection Market Facts & Figures by Country
3.5.1 Europe Long-acting Glucocorticoid Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Long-acting Glucocorticoid Injection Sales by Country (2021–2032)
3.5.3 Europe Long-acting Glucocorticoid Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Long-acting Glucocorticoid Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Long-acting Glucocorticoid Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Long-acting Glucocorticoid Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Long-acting Glucocorticoid Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Long-acting Glucocorticoid Injection Market Facts & Figures by Country
3.7.1 Latin America Long-acting Glucocorticoid Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Long-acting Glucocorticoid Injection Sales by Country (2021–2032)
3.7.3 Latin America Long-acting Glucocorticoid Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Long-acting Glucocorticoid Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Long-acting Glucocorticoid Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Long-acting Glucocorticoid Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Long-acting Glucocorticoid Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Long-acting Glucocorticoid Injection Sales by Type (2021–2032)
4.1.1 Global Long-acting Glucocorticoid Injection Sales by Type (2021–2026)
4.1.2 Global Long-acting Glucocorticoid Injection Sales by Type (2027–2032)
4.1.3 Global Long-acting Glucocorticoid Injection Sales Market Share by Type (2021–2032)
4.2 Global Long-acting Glucocorticoid Injection Revenue by Type (2021–2032)
4.2.1 Global Long-acting Glucocorticoid Injection Revenue by Type (2021–2026)
4.2.2 Global Long-acting Glucocorticoid Injection Revenue by Type (2027–2032)
4.2.3 Global Long-acting Glucocorticoid Injection Revenue Market Share by Type (2021–2032)
4.3 Global Long-acting Glucocorticoid Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Long-acting Glucocorticoid Injection Sales by Application (2021–2032)
5.1.1 Global Long-acting Glucocorticoid Injection Sales by Application (2021–2026)
5.1.2 Global Long-acting Glucocorticoid Injection Sales by Application (2027–2032)
5.1.3 Global Long-acting Glucocorticoid Injection Sales Market Share by Application (2021–2032)
5.2 Global Long-acting Glucocorticoid Injection Revenue by Application (2021–2032)
5.2.1 Global Long-acting Glucocorticoid Injection Revenue by Application (2021–2026)
5.2.2 Global Long-acting Glucocorticoid Injection Revenue by Application (2027–2032)
5.2.3 Global Long-acting Glucocorticoid Injection Revenue Market Share by Application (2021–2032)
5.3 Global Long-acting Glucocorticoid Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Eurocrit Labs
6.1.1 Eurocrit Labs Company Information
6.1.2 Eurocrit Labs Description and Business Overview
6.1.3 Eurocrit Labs Long-acting Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Eurocrit Labs Long-acting Glucocorticoid Injection Product Portfolio
6.1.5 Eurocrit Labs Recent Developments/Updates
6.2 Pyxus Pharmaceutical
6.2.1 Pyxus Pharmaceutical Company Information
6.2.2 Pyxus Pharmaceutical Description and Business Overview
6.2.3 Pyxus Pharmaceutical Long-acting Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pyxus Pharmaceutical Long-acting Glucocorticoid Injection Product Portfolio
6.2.5 Pyxus Pharmaceutical Recent Developments/Updates
6.3 SiNi Pharma
6.3.1 SiNi Pharma Company Information
6.3.2 SiNi Pharma Description and Business Overview
6.3.3 SiNi Pharma Long-acting Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 SiNi Pharma Long-acting Glucocorticoid Injection Product Portfolio
6.3.5 SiNi Pharma Recent Developments/Updates
6.4 Zydus Cadila
6.4.1 Zydus Cadila Company Information
6.4.2 Zydus Cadila Description and Business Overview
6.4.3 Zydus Cadila Long-acting Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Zydus Cadila Long-acting Glucocorticoid Injection Product Portfolio
6.4.5 Zydus Cadila Recent Developments/Updates
6.5 Weefsel Pharma
6.5.1 Weefsel Pharma Company Information
6.5.2 Weefsel Pharma Description and Business Overview
6.5.3 Weefsel Pharma Long-acting Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Weefsel Pharma Long-acting Glucocorticoid Injection Product Portfolio
6.5.5 Weefsel Pharma Recent Developments/Updates
6.6 Taj Pharmaceuticals Limited
6.6.1 Taj Pharmaceuticals Limited Company Information
6.6.2 Taj Pharmaceuticals Limited Description and Business Overview
6.6.3 Taj Pharmaceuticals Limited Long-acting Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Taj Pharmaceuticals Limited Long-acting Glucocorticoid Injection Product Portfolio
6.6.5 Taj Pharmaceuticals Limited Recent Developments/Updates
6.7 Wellona Pharma
6.7.1 Wellona Pharma Company Information
6.7.2 Wellona Pharma Description and Business Overview
6.7.3 Wellona Pharma Long-acting Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Wellona Pharma Long-acting Glucocorticoid Injection Product Portfolio
6.7.5 Wellona Pharma Recent Developments/Updates
6.8 Caspian Tamin Pharmaceutical Company
6.8.1 Caspian Tamin Pharmaceutical Company Company Information
6.8.2 Caspian Tamin Pharmaceutical Company Description and Business Overview
6.8.3 Caspian Tamin Pharmaceutical Company Long-acting Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Caspian Tamin Pharmaceutical Company Long-acting Glucocorticoid Injection Product Portfolio
6.8.5 Caspian Tamin Pharmaceutical Company Recent Developments/Updates
6.9 AdvaCare Pharma
6.9.1 AdvaCare Pharma Company Information
6.9.2 AdvaCare Pharma Description and Business Overview
6.9.3 AdvaCare Pharma Long-acting Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 AdvaCare Pharma Long-acting Glucocorticoid Injection Product Portfolio
6.9.5 AdvaCare Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Long-acting Glucocorticoid Injection Industry Chain Analysis
7.2 Long-acting Glucocorticoid Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Long-acting Glucocorticoid Injection Production Mode & Process Analysis
7.4 Long-acting Glucocorticoid Injection Sales and Marketing
7.4.1 Long-acting Glucocorticoid Injection Sales Channels
7.4.2 Long-acting Glucocorticoid Injection Distributors
7.5 Long-acting Glucocorticoid Injection Customer Analysis
8 Long-acting Glucocorticoid Injection Market Dynamics
8.1 Long-acting Glucocorticoid Injection Industry Trends
8.2 Long-acting Glucocorticoid Injection Market Drivers
8.3 Long-acting Glucocorticoid Injection Market Challenges
8.4 Long-acting Glucocorticoid Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Long-acting Glucocorticoid Injection Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Long-acting Glucocorticoid Injection Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Long-acting Glucocorticoid Injection Market Competitive Situation by Manufacturers in 2025
Table 4. Global Long-acting Glucocorticoid Injection Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Long-acting Glucocorticoid Injection Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Long-acting Glucocorticoid Injection Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Long-acting Glucocorticoid Injection Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Long-acting Glucocorticoid Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Long-acting Glucocorticoid Injection, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Long-acting Glucocorticoid Injection, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Long-acting Glucocorticoid Injection, Product Types and Applications
Table 12. Global Key Manufacturers of Long-acting Glucocorticoid Injection, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Long-acting Glucocorticoid Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Long-acting Glucocorticoid Injection Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Long-acting Glucocorticoid Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Long-acting Glucocorticoid Injection Sales by Region (K Units), 2021–2026
Table 18. Global Long-acting Glucocorticoid Injection Sales Market Share by Region (2021–2026)
Table 19. Global Long-acting Glucocorticoid Injection Sales by Region (K Units), 2027–2032
Table 20. Global Long-acting Glucocorticoid Injection Sales Market Share by Region (2027–2032)
Table 21. Global Long-acting Glucocorticoid Injection Revenue by Region (US$ Million), 2021–2026
Table 22. Global Long-acting Glucocorticoid Injection Revenue Market Share by Region (2021–2026)
Table 23. Global Long-acting Glucocorticoid Injection Revenue by Region (US$ Million), 2027–2032
Table 24. Global Long-acting Glucocorticoid Injection Revenue Market Share by Region (2027–2032)
Table 25. North America Long-acting Glucocorticoid Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Long-acting Glucocorticoid Injection Sales by Country (K Units), 2021–2026
Table 27. North America Long-acting Glucocorticoid Injection Sales by Country (K Units), 2027–2032
Table 28. North America Long-acting Glucocorticoid Injection Revenue by Country (US$ Million), 2021–2026
Table 29. North America Long-acting Glucocorticoid Injection Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Long-acting Glucocorticoid Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Long-acting Glucocorticoid Injection Sales by Country (K Units), 2021–2026
Table 32. Europe Long-acting Glucocorticoid Injection Sales by Country (K Units), 2027–2032
Table 33. Europe Long-acting Glucocorticoid Injection Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Long-acting Glucocorticoid Injection Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Long-acting Glucocorticoid Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Long-acting Glucocorticoid Injection Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Long-acting Glucocorticoid Injection Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Long-acting Glucocorticoid Injection Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Long-acting Glucocorticoid Injection Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Long-acting Glucocorticoid Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Long-acting Glucocorticoid Injection Sales by Country (K Units), 2021–2026
Table 42. Latin America Long-acting Glucocorticoid Injection Sales by Country (K Units), 2027–2032
Table 43. Latin America Long-acting Glucocorticoid Injection Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Long-acting Glucocorticoid Injection Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Long-acting Glucocorticoid Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Long-acting Glucocorticoid Injection Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Long-acting Glucocorticoid Injection Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Long-acting Glucocorticoid Injection Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Long-acting Glucocorticoid Injection Revenue by Country (US$ Million), 2027–2032
Table 50. Global Long-acting Glucocorticoid Injection Sales (K Units) by Type (2021–2026)
Table 51. Global Long-acting Glucocorticoid Injection Sales (K Units) by Type (2027–2032)
Table 52. Global Long-acting Glucocorticoid Injection Sales Market Share by Type (2021–2026)
Table 53. Global Long-acting Glucocorticoid Injection Sales Market Share by Type (2027–2032)
Table 54. Global Long-acting Glucocorticoid Injection Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Long-acting Glucocorticoid Injection Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Long-acting Glucocorticoid Injection Revenue Market Share by Type (2021–2026)
Table 57. Global Long-acting Glucocorticoid Injection Revenue Market Share by Type (2027–2032)
Table 58. Global Long-acting Glucocorticoid Injection Price (US$/Unit) by Type (2021–2026)
Table 59. Global Long-acting Glucocorticoid Injection Price (US$/Unit) by Type (2027–2032)
Table 60. Global Long-acting Glucocorticoid Injection Sales (K Units) by Application (2021–2026)
Table 61. Global Long-acting Glucocorticoid Injection Sales (K Units) by Application (2027–2032)
Table 62. Global Long-acting Glucocorticoid Injection Sales Market Share by Application (2021–2026)
Table 63. Global Long-acting Glucocorticoid Injection Sales Market Share by Application (2027–2032)
Table 64. Global Long-acting Glucocorticoid Injection Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Long-acting Glucocorticoid Injection Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Long-acting Glucocorticoid Injection Revenue Market Share by Application (2021–2026)
Table 67. Global Long-acting Glucocorticoid Injection Revenue Market Share by Application (2027–2032)
Table 68. Global Long-acting Glucocorticoid Injection Price (US$/Unit) by Application (2021–2026)
Table 69. Global Long-acting Glucocorticoid Injection Price (US$/Unit) by Application (2027–2032)
Table 70. Eurocrit Labs Company Information
Table 71. Eurocrit Labs Description and Business Overview
Table 72. Eurocrit Labs Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Eurocrit Labs Long-acting Glucocorticoid Injection Product
Table 74. Eurocrit Labs Recent Developments/Updates
Table 75. Pyxus Pharmaceutical Company Information
Table 76. Pyxus Pharmaceutical Description and Business Overview
Table 77. Pyxus Pharmaceutical Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Pyxus Pharmaceutical Long-acting Glucocorticoid Injection Product
Table 79. Pyxus Pharmaceutical Recent Developments/Updates
Table 80. SiNi Pharma Company Information
Table 81. SiNi Pharma Description and Business Overview
Table 82. SiNi Pharma Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. SiNi Pharma Long-acting Glucocorticoid Injection Product
Table 84. SiNi Pharma Recent Developments/Updates
Table 85. Zydus Cadila Company Information
Table 86. Zydus Cadila Description and Business Overview
Table 87. Zydus Cadila Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Zydus Cadila Long-acting Glucocorticoid Injection Product
Table 89. Zydus Cadila Recent Developments/Updates
Table 90. Weefsel Pharma Company Information
Table 91. Weefsel Pharma Description and Business Overview
Table 92. Weefsel Pharma Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Weefsel Pharma Long-acting Glucocorticoid Injection Product
Table 94. Weefsel Pharma Recent Developments/Updates
Table 95. Taj Pharmaceuticals Limited Company Information
Table 96. Taj Pharmaceuticals Limited Description and Business Overview
Table 97. Taj Pharmaceuticals Limited Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Taj Pharmaceuticals Limited Long-acting Glucocorticoid Injection Product
Table 99. Taj Pharmaceuticals Limited Recent Developments/Updates
Table 100. Wellona Pharma Company Information
Table 101. Wellona Pharma Description and Business Overview
Table 102. Wellona Pharma Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Wellona Pharma Long-acting Glucocorticoid Injection Product
Table 104. Wellona Pharma Recent Developments/Updates
Table 105. Caspian Tamin Pharmaceutical Company Company Information
Table 106. Caspian Tamin Pharmaceutical Company Description and Business Overview
Table 107. Caspian Tamin Pharmaceutical Company Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Caspian Tamin Pharmaceutical Company Long-acting Glucocorticoid Injection Product
Table 109. Caspian Tamin Pharmaceutical Company Recent Developments/Updates
Table 110. AdvaCare Pharma Company Information
Table 111. AdvaCare Pharma Description and Business Overview
Table 112. AdvaCare Pharma Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. AdvaCare Pharma Long-acting Glucocorticoid Injection Product
Table 114. AdvaCare Pharma Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Long-acting Glucocorticoid Injection Distributors List
Table 118. Long-acting Glucocorticoid Injection Customers List
Table 119. Long-acting Glucocorticoid Injection Market Trends
Table 120. Long-acting Glucocorticoid Injection Market Drivers
Table 121. Long-acting Glucocorticoid Injection Market Challenges
Table 122. Long-acting Glucocorticoid Injection Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Long-acting Glucocorticoid Injection
Figure 2. Global Long-acting Glucocorticoid Injection Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Long-acting Glucocorticoid Injection Market Share by Type: 2025 & 2032
Figure 4. Dexamethasone Hormone Injection Product Picture
Figure 5. Betamethasone Hormone Injection Product Picture
Figure 6. Global Long-acting Glucocorticoid Injection Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Long-acting Glucocorticoid Injection Market Share by Application: 2025 & 2032
Figure 8. Rheumatoid Arthritis
Figure 9. Allergic Diseases
Figure 10. Bronchial Asthma
Figure 11. Autoimmune Disease
Figure 12. Skin Diseases
Figure 13. Others
Figure 14. Global Long-acting Glucocorticoid Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Long-acting Glucocorticoid Injection Market Size (US$ Million), 2021–2032
Figure 16. Global Long-acting Glucocorticoid Injection Sales (K Units), 2021–2032
Figure 17. Global Long-acting Glucocorticoid Injection Average Price (US$/Unit), 2021–2032
Figure 18. Long-acting Glucocorticoid Injection Report Years Considered
Figure 19. Long-acting Glucocorticoid Injection Sales Share by Manufacturers in 2025
Figure 20. Global Long-acting Glucocorticoid Injection Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global Long-acting Glucocorticoid Injection Players: Market Share by Revenue in Long-acting Glucocorticoid Injection in 2025
Figure 22. Long-acting Glucocorticoid Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global Long-acting Glucocorticoid Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America Long-acting Glucocorticoid Injection Sales Market Share by Country (2021–2032)
Figure 25. North America Long-acting Glucocorticoid Injection Revenue Market Share by Country (2021–2032)
Figure 26. United States Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe Long-acting Glucocorticoid Injection Sales Market Share by Country (2021–2032)
Figure 29. Europe Long-acting Glucocorticoid Injection Revenue Market Share by Country (2021–2032)
Figure 30. Germany Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific Long-acting Glucocorticoid Injection Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific Long-acting Glucocorticoid Injection Revenue Market Share by Region (2021–2032)
Figure 37. China Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Long-acting Glucocorticoid Injection Sales Market Share by Country (2021–2032)
Figure 45. Latin America Long-acting Glucocorticoid Injection Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Long-acting Glucocorticoid Injection Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Long-acting Glucocorticoid Injection Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Long-acting Glucocorticoid Injection by Type (2021–2032)
Figure 56. Global Revenue Market Share of Long-acting Glucocorticoid Injection by Type (2021–2032)
Figure 57. Global Long-acting Glucocorticoid Injection Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Long-acting Glucocorticoid Injection by Application (2021–2032)
Figure 59. Global Revenue Market Share of Long-acting Glucocorticoid Injection by Application (2021–2032)
Figure 60. Global Long-acting Glucocorticoid Injection Price (US$/Unit) by Application (2021–2032)
Figure 61. Long-acting Glucocorticoid Injection Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
